Literature DB >> 25220416

Growth-promoting and tumourigenic activity of c-Myc is suppressed by Hhex.

V Marfil1, M Blazquez1, F Serrano1, J V Castell1, R Bort1.   

Abstract

c-Myc transcription factor is a key protein involved in cellular growth, proliferation and metabolism. c-Myc is one of the most frequently activated oncogenes, highlighting the need to identify intracellular molecules that interact directly with c-Myc to suppress its function. Here we show that Hhex is able to interact with the basic region/helix-loop-helix/leucine zipper of c-Myc. Knockdown of Hhex increases proliferation rate in hepatocellular carcinoma cells, whereas Hhex expression cell-autonomously reduces cell proliferation rate in multiple cell lines by increasing G1 phase length through a c-Myc-dependent mechanism. Global transcriptomic analysis shows that Hhex counter-regulates multiple c-Myc targets involved in cell proliferation and metabolism. Concomitantly, Hhex expression leads to reduced cell size, lower levels of cellular RNA, downregulation of metabolism-related genes, decreased sensitivity to methotrexate and severe reduction in the ability to form tumours in nude mouse xenografts, all indicative of decreased c-Myc activity. Our data suggest that Hhex is a novel regulator of c-Myc function that limits c-Myc activity in transformed cells.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25220416     DOI: 10.1038/onc.2014.240

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  66 in total

1.  Hex homeobox gene controls the transition of the endoderm to a pseudostratified, cell emergent epithelium for liver bud development.

Authors:  Roque Bort; Massimo Signore; Kimberly Tremblay; Juan Pedro Martinez Barbera; Kenneth S Zaret
Journal:  Dev Biol       Date:  2005-12-20       Impact factor: 3.582

2.  Transcriptional amplification in tumor cells with elevated c-Myc.

Authors:  Charles Y Lin; Jakob Lovén; Peter B Rahl; Ronald M Paranal; Christopher B Burge; James E Bradner; Tong Ihn Lee; Richard A Young
Journal:  Cell       Date:  2012-09-28       Impact factor: 41.582

3.  PML4 induces differentiation by Myc destabilization.

Authors:  M Buschbeck; I Uribesalgo; A Ledl; A Gutierrez; S Minucci; S Muller; L Di Croce
Journal:  Oncogene       Date:  2006-12-04       Impact factor: 9.867

4.  c-Myc regulates mammalian body size by controlling cell number but not cell size.

Authors:  A Trumpp; Y Refaeli; T Oskarsson; S Gasser; M Murphy; G R Martin; J M Bishop
Journal:  Nature       Date:  2001-12-13       Impact factor: 49.962

Review 5.  MYC oncogenes and human neoplastic disease.

Authors:  C E Nesbit; J M Tersak; E V Prochownik
Journal:  Oncogene       Date:  1999-05-13       Impact factor: 9.867

6.  Regulation of gene expression in hepatic cells by the mammalian Target of Rapamycin (mTOR).

Authors:  Rosa H Jimenez; Ju-Seog Lee; Mirko Francesconi; Gastone Castellani; Nicola Neretti; Jennifer A Sanders; John Sedivy; Philip A Gruppuso
Journal:  PLoS One       Date:  2010-02-05       Impact factor: 3.240

7.  The proline-rich homeodomain protein recruits members of the Groucho/Transducin-like enhancer of split protein family to co-repress transcription in hematopoietic cells.

Authors:  Tracey E Swingler; Kirstin L Bess; Jing Yao; Stefano Stifani; Padma-Sheela Jayaraman
Journal:  J Biol Chem       Date:  2004-06-07       Impact factor: 5.157

8.  Multiple independent binding sites for small-molecule inhibitors on the oncoprotein c-Myc.

Authors:  Dalia I Hammoudeh; Ariele Viacava Follis; Edward V Prochownik; Steven J Metallo
Journal:  J Am Chem Soc       Date:  2009-06-03       Impact factor: 15.419

9.  The homeobox gene Hex is required in definitive endodermal tissues for normal forebrain, liver and thyroid formation.

Authors:  J P Martinez Barbera; M Clements; P Thomas; T Rodriguez; D Meloy; D Kioussis; R S Beddington
Journal:  Development       Date:  2000-06       Impact factor: 6.868

10.  HEX expression and localization in normal mammary gland and breast carcinoma.

Authors:  Cinzia Puppin; Fabio Puglisi; Lucia Pellizzari; Guidalberto Manfioletti; Marta Pestrin; Maura Pandolfi; Andrea Piga; Carla Di Loreto; Giuseppe Damante
Journal:  BMC Cancer       Date:  2006-07-19       Impact factor: 4.430

View more
  11 in total

1.  Metformin inhibits thyroid cancer cell growth, migration, and EMT through the mTOR pathway.

Authors:  Baiyu Han; Hanzhi Cui; Lei Kang; Xuelin Zhang; Zhitao Jin; Lanmin Lu; Zhongyi Fan
Journal:  Tumour Biol       Date:  2015-04-09

2.  The tumor suppressor HHEX inhibits axon growth when prematurely expressed in developing central nervous system neurons.

Authors:  Matthew T Simpson; Ishwariya Venkatesh; Ben L Callif; Laura K Thiel; Denise M Coley; Kristen N Winsor; Zimei Wang; Audra A Kramer; Jessica K Lerch; Murray G Blackmore
Journal:  Mol Cell Neurosci       Date:  2015-08-23       Impact factor: 4.314

Review 3.  Misregulation of the proline rich homeodomain (PRH/HHEX) protein in cancer cells and its consequences for tumour growth and invasion.

Authors:  Kevin Gaston; Maria-Angela Tsitsilianos; Kerry Wadey; Padma-Sheela Jayaraman
Journal:  Cell Biosci       Date:  2016-02-13       Impact factor: 7.133

4.  Two variants on T2DM susceptible gene HHEX are associated with CRC risk in a Chinese population.

Authors:  Rui Sun; Jian-Ping Liu; Chang Gao; Ying-Ying Xiong; Min Li; Ya-Ping Wang; Yan-Wei Su; Mei Lin; An-Li Jiang; Ling-Fan Xiong; Yan Xie; Jue-Ping Feng
Journal:  Oncotarget       Date:  2016-05-17

5.  Proline-Rich Homeodomain protein (PRH/HHEX) is a suppressor of breast tumour growth.

Authors:  R M Kershaw; D Roberts; J Wragg; A M Shaaban; E Humphreys; J Halsall; L Price; R Bicknell; K Gaston; P-S Jayaraman
Journal:  Oncogenesis       Date:  2017-06-12       Impact factor: 7.485

6.  CK2 abrogates the inhibitory effects of PRH/HHEX on prostate cancer cell migration and invasion and acts through PRH to control cell proliferation.

Authors:  Y H Siddiqui; R M Kershaw; E H Humphreys; E M Assis Junior; S Chaudhri; P-S Jayaraman; K Gaston
Journal:  Oncogenesis       Date:  2017-01-30       Impact factor: 7.485

7.  Direct conversion of human fibroblast to hepatocytes using a single inducible polycistronic vector.

Authors:  Maria Ballester; Miguel Bolonio; Ramon Santamaria; José V Castell; Carmen Ribes-Koninckx; Roque Bort
Journal:  Stem Cell Res Ther       Date:  2019-11-04       Impact factor: 6.832

Review 8.  The Quest for Targets Executing MYC-Dependent Cell Transformation.

Authors:  Markus Hartl
Journal:  Front Oncol       Date:  2016-06-02       Impact factor: 6.244

9.  Silencing of hepatic fate-conversion factors induce tumorigenesis in reprogrammed hepatic progenitor-like cells.

Authors:  Felipe Serrano; Maria García-Bravo; Marina Blazquez; Josema Torres; Jose V Castell; Jose C Segovia; Roque Bort
Journal:  Stem Cell Res Ther       Date:  2016-07-27       Impact factor: 6.832

10.  Permissive selection followed by affinity-based proliferation of GC light zone B cells dictates cell fate and ensures clonal breadth.

Authors:  Rinako Nakagawa; Amparo Toboso-Navasa; Marta Schips; George Young; Leena Bhaw-Rosun; Miriam Llorian-Sopena; Probir Chakravarty; Abdul Karim Sesay; George Kassiotis; Michael Meyer-Hermann; Dinis Pedro Calado
Journal:  Proc Natl Acad Sci U S A       Date:  2021-01-12       Impact factor: 12.779

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.